Stocks

Moleculin Biotech MBRX

Health care sectorNasdaq

What to see in Moleculin Biotech now

Who bought more than 5%?6.3%

Jonathan P. Foster holds 6.3%

Filed 08/25

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Houston, Texas
Fiscal year end
12/31
Next earnings
11/13, estimated
  • Jonathan P. Foster holds 6.3%Filed 08/25

5% stakes

Holder
Jonathan P. Foster08/256.3%1,288,207 shFirst report
Walter V. Klemp08/259.9%2,070,761 shFirst report
CVI Investments08/109.9%1,863,377 shFirst report
Intracoastal Capital08/064.99%973,927 shFirst report
Armistice Capital25/08/144.99%1,586,521 sh−3.9pp
Armistice Capital25/05/158.93%1,250,000 sh−1.1pp
All 5% stake reports on Moleculin Biotech

26-week trading